# THERAPEUTIC OLIGONUCLEOTIDE PLATFORM BIOLOGICS CHEMISTRY, MANUFACTURING AND CONTROLS (CMC), SUBJECT MATTER EXPERT CONSULTING SERVICES.

> **NIH NIH N02** · — · 2024 · $71,775

## Abstract

The National Institutes of Health (NIH) is seeking a highly experienced, senior-level, biological
therapeutics development consultant with expertise in Therapeutic Oligonucleotide Platform
Biologics Chemistry, Manufacturing and Controls (CMC). This individual would be expected to
provide guidance and advice on biologics development processes for the National Institute of
Neurological Disorders and Stroke (NINDS) Ultra-Rare Gene Therapy (URGenT) program, the
NIH Blueprint Neurotherapeutics (BPN) Biologics program, and other NINDS and trans-NIH
programs where therapeutic oligonucleotide CMC expertise is required.

## Key facts

- **NIH application ID:** 11199869
- **Project number:** 75N95024P00008-0-0-1
- **Recipient organization:** —
- **Principal Investigator:** —
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $71,775
- **Award type:** —
- **Project period:** 2023-10-16 → 2026-10-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11199869

## Citation

> US National Institutes of Health, RePORTER application 11199869, THERAPEUTIC OLIGONUCLEOTIDE PLATFORM BIOLOGICS CHEMISTRY, MANUFACTURING AND CONTROLS (CMC), SUBJECT MATTER EXPERT CONSULTING SERVICES. (75N95024P00008-0-0-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11199869. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*